Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
J

Jayamas Medica Industri TBK PT
IDX:OMED

Watchlist Manager
Jayamas Medica Industri TBK PT
IDX:OMED
Watchlist
Price: 210 IDR Market Closed
Market Cap: Rp5.7T
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Revenue
+
3Y
-
5Y
-
10Y
-
Operating Income
+
3Y
-
5Y
-
10Y
-
Net Income
+
3Y
-
5Y
-
10Y
-

Earnings Waterfall
Jayamas Medica Industri TBK PT

Income Statement
Jayamas Medica Industri TBK PT

Rotate your device to view
Income Statement
Currency: IDR
Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
20 653
11 443
16 019
20 571
19 413
19 556
19 584
19 618
19 582
19 443
0
0
Revenue
1 739 054
N/A
2 135 951
+23%
2 550 396
+19%
3 005 525
+18%
1 736 990
-42%
1 767 482
+2%
1 805 296
+2%
1 835 015
+2%
1 885 822
+3%
1 894 749
+0%
1 932 020
+2%
1 991 221
+3%
Gross Profit
Cost of Revenue
(1 186 562)
(1 455 607)
(1 733 948)
(2 053 382)
(1 184 990)
(1 204 632)
(1 225 205)
(1 235 704)
(1 261 846)
(1 262 592)
(1 286 141)
(1 312 642)
Gross Profit
552 492
N/A
680 345
+23%
816 448
+20%
952 143
+17%
552 000
-42%
562 849
+2%
580 091
+3%
599 310
+3%
623 976
+4%
632 157
+1%
645 879
+2%
678 579
+5%
Operating Income
Operating Expenses
(180 587)
(239 043)
(307 049)
(367 274)
(252 340)
(253 791)
(259 819)
(284 511)
(278 518)
(292 990)
(284 742)
(262 602)
Selling, General & Administrative
(161 261)
(213 566)
(275 948)
(343 625)
(221 875)
(242 755)
(250 956)
(247 190)
(255 432)
(280 962)
(274 465)
(292 678)
Depreciation & Amortization
(22 939)
(28 983)
(35 527)
(36 190)
(25 810)
(15 380)
(9 898)
(10 333)
(20 070)
(14 274)
(18 914)
(19 184)
Other Operating Expenses
3 613
3 506
4 426
12 542
(4 656)
4 344
1 035
(26 988)
(3 016)
2 246
8 637
49 260
Operating Income
371 905
N/A
441 301
+19%
509 399
+15%
584 869
+15%
299 660
-49%
309 059
+3%
320 272
+4%
314 800
-2%
345 458
+10%
339 167
-2%
361 136
+6%
415 977
+15%
Pre-Tax Income
Interest Income Expense
270
(1 106)
629
11 472
25 593
31 718
49 757
52 151
49 151
66 603
44 048
31 760
Non-Reccuring Items
0
0
2
293
1 251
0
1 113
1 103
(121)
(363)
266
(594)
Total Other Income
(67)
(81)
(94)
(314)
(341)
(430)
(532)
(435)
(461)
(472)
(472)
(495)
Pre-Tax Income
372 109
N/A
440 114
+18%
509 936
+16%
596 320
+17%
326 162
-45%
340 347
+4%
370 611
+9%
367 618
-1%
394 026
+7%
404 936
+3%
404 978
+0%
446 648
+10%
Net Income
Tax Provision
(81 602)
(92 627)
(107 779)
(122 326)
(65 180)
(72 263)
(76 040)
(77 525)
(70 074)
(71 978)
(71 585)
(79 523)
Income from Continuing Operations
290 507
347 487
402 157
473 994
260 982
268 084
294 571
290 093
323 952
332 957
333 393
367 125
Income to Minority Interest
(4 725)
(5 282)
(5 763)
(5 829)
(1 622)
(1 687)
(1 874)
(2 190)
(2 279)
(1 981)
(1 937)
(2 170)
Net Income (Common)
285 782
N/A
342 205
+20%
396 394
+16%
468 166
+18%
259 360
-45%
266 397
+3%
292 696
+10%
287 902
-2%
321 673
+12%
330 977
+3%
331 456
+0%
364 955
+10%
EPS (Diluted)
10.56
N/A
14.87
+41%
17.23
+16%
20.35
+18%
9.59
-53%
9.84
+3%
10.81
+10%
10.64
-2%
11.89
+12%
12.23
+3%
12.25
+0%
13.49
+10%

See Also

Summary
OMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
OMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OMED stock valuation using valuation multiples.
Wall Street Estimates
OMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 320,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.